Viatris Inc. (VTRS)
USD 8.06
(3.2%)
USD 8.06
(3.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.43 Billion USD | -0.9% |
| 2022 | 6.49 Billion USD | 16.53% |
| 2021 | 5.57 Billion USD | 46.85% |
| 2020 | 3.79 Billion USD | -14.57% |
| 2019 | 4.44 Billion USD | -2.8% |
| 2018 | 4.57 Billion USD | -8.12% |
| 2017 | 4.97 Billion USD | -0.45% |
| 2016 | 4.99 Billion USD | 14.06% |
| 2015 | 4.38 Billion USD | 19.43% |
| 2014 | 3.66 Billion USD | 17.87% |
| 2013 | 3.11 Billion USD | 1.74% |
| 2012 | 3.05 Billion USD | 18.37% |
| 2011 | 2.58 Billion USD | 16.7% |
| 2010 | 2.21 Billion USD | 6.78% |
| 2009 | 2.07 Billion USD | 0.21% |
| 2008 | 2.07 Billion USD | 77.56% |
| 2007 | 1.16 Billion USD | 0.0% |
| 2006 | 627.61 Million USD | 0.65% |
| 2005 | 627.61 Million USD | 0.65% |
| 2004 | 623.54 Million USD | -18.22% |
| 2003 | 762.46 Million USD | 0.0% |
| 2002 | 623.93 Million USD | 46.96% |
| 2001 | 424.56 Million USD | -8.5% |
| 2000 | 464.03 Million USD | 12.85% |
| 1999 | 411.2 Million USD | 56.95% |
| 1998 | 262 Million USD | 32.46% |
| 1997 | 197.8 Million USD | -5.22% |
| 1996 | 208.7 Million USD | -12.75% |
| 1995 | 239.2 Million USD | 74.09% |
| 1994 | 137.4 Million USD | 7.6% |
| 1993 | 127.7 Million USD | 90.31% |
| 1992 | 67.1 Million USD | 71.61% |
| 1991 | 39.1 Million USD | -2.01% |
| 1990 | 39.9 Million USD | 4.72% |
| 1989 | 38.1 Million USD | -27.98% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.5 Billion USD | -5.79% |
| 2024 Q2 | 1.49 Billion USD | -0.72% |
| 2023 Q2 | 1.6 Billion USD | 4.31% |
| 2023 Q3 | 1.69 Billion USD | 5.14% |
| 2023 Q4 | 1.59 Billion USD | -5.61% |
| 2023 Q1 | 1.54 Billion USD | -2.99% |
| 2023 FY | 6.56 Billion USD | 1.09% |
| 2022 Q4 | 1.58 Billion USD | -13.71% |
| 2022 FY | 6.49 Billion USD | 16.53% |
| 2022 Q3 | 1.84 Billion USD | 4.3% |
| 2022 Q2 | 1.76 Billion USD | -3.71% |
| 2022 Q1 | 1.83 Billion USD | -1.71% |
| 2021 Q4 | 1.86 Billion USD | -8.57% |
| 2021 Q2 | 1.98 Billion USD | 6.63% |
| 2021 Q3 | 2.04 Billion USD | 2.87% |
| 2021 FY | 5.57 Billion USD | 46.85% |
| 2021 Q1 | 1.86 Billion USD | 61.3% |
| 2020 Q4 | 1.15 Billion USD | -8.46% |
| 2020 Q1 | 1.02 Billion USD | -22.52% |
| 2020 Q2 | 1.13 Billion USD | 9.99% |
| 2020 Q3 | 1.26 Billion USD | 11.46% |
| 2020 FY | 3.79 Billion USD | -2.59% |
| 2019 FY | 3.89 Billion USD | -2.6% |
| 2019 Q3 | 1.15 Billion USD | 2.15% |
| 2019 Q4 | 1.32 Billion USD | 14.63% |
| 2019 Q1 | 934.8 Million USD | -25.78% |
| 2019 Q2 | 1.13 Billion USD | 21.2% |
| 2018 Q4 | 1.25 Billion USD | 7.35% |
| 2018 Q1 | 998.9 Million USD | -28.46% |
| 2018 FY | 4 Billion USD | -16.34% |
| 2018 Q2 | 1.11 Billion USD | 11.15% |
| 2018 Q3 | 1.17 Billion USD | 5.67% |
| 2017 Q2 | 1.24 Billion USD | 12.05% |
| 2017 Q1 | 1.11 Billion USD | -28.27% |
| 2017 FY | 4.78 Billion USD | 1.83% |
| 2017 Q3 | 1.21 Billion USD | -2.7% |
| 2017 Q4 | 1.39 Billion USD | 15.28% |
| 2016 Q2 | 1.19 Billion USD | 27.09% |
| 2016 Q3 | 1.36 Billion USD | 14.55% |
| 2016 Q4 | 1.54 Billion USD | 13.09% |
| 2016 FY | 4.69 Billion USD | 11.41% |
| 2016 Q1 | 940.7 Million USD | -17.86% |
| 2015 Q3 | 1.34 Billion USD | 29.18% |
| 2015 Q1 | 850.4 Million USD | -17.09% |
| 2015 FY | 4.21 Billion USD | 19.5% |
| 2015 Q4 | 1.14 Billion USD | -14.87% |
| 2015 Q2 | 1.04 Billion USD | 22.46% |
| 2014 Q3 | 1.04 Billion USD | 24.51% |
| 2014 Q2 | 836.5 Million USD | 9.25% |
| 2014 Q1 | 765.7 Million USD | -8.49% |
| 2014 Q4 | 1.02 Billion USD | -1.52% |
| 2014 FY | 3.52 Billion USD | 16.04% |
| 2013 Q3 | 818.1 Million USD | 0.0% |
| 2013 Q1 | 693.49 Million USD | -6.58% |
| 2013 Q4 | 836.7 Million USD | 2.27% |
| 2013 FY | 3.04 Billion USD | 4.54% |
| 2013 Q2 | 742.38 Million USD | 7.05% |
| 2012 FY | 2.9 Billion USD | 13.46% |
| 2012 Q4 | 742.31 Million USD | -5.86% |
| 2012 Q3 | 788.52 Million USD | 12.78% |
| 2012 Q2 | 699.17 Million USD | 4.94% |
| 2012 Q1 | 666.27 Million USD | 3.36% |
| 2011 Q1 | 590.94 Million USD | 2.03% |
| 2011 FY | 2.56 Billion USD | 15.6% |
| 2011 Q2 | 669.42 Million USD | 13.28% |
| 2011 Q4 | 644.59 Million USD | -2.09% |
| 2011 Q3 | 658.39 Million USD | -1.65% |
| 2010 Q4 | 579.19 Million USD | -0.15% |
| 2010 Q1 | 516.29 Million USD | 0.06% |
| 2010 Q2 | 541.85 Million USD | 4.95% |
| 2010 Q3 | 580.05 Million USD | 7.05% |
| 2010 FY | 2.21 Billion USD | 6.89% |
| 2009 Q3 | 504.98 Million USD | -4.32% |
| 2009 Q4 | 515.99 Million USD | 2.18% |
| 2009 Q1 | 525.73 Million USD | 33.21% |
| 2009 FY | 2.07 Billion USD | 0.21% |
| 2009 Q2 | 527.76 Million USD | 0.39% |
| 2008 Q4 | 394.65 Million USD | -56.69% |
| 2008 Q3 | 911.13 Million USD | 119.97% |
| 2008 Q1 | 350.22 Million USD | 0.0% |
| 2008 Q2 | 414.21 Million USD | 18.27% |
| 2008 FY | 2.07 Billion USD | 145.38% |
| 2007 Q3 | 221.64 Million USD | -25.3% |
| 2007 Q4 | - USD | -100.0% |
| 2007 FY | 843.66 Million USD | 34.42% |
| 2007 Q1 | 234.84 Million USD | 4.59% |
| 2007 Q2 | 296.7 Million USD | 26.34% |
| 2006 Q2 | 188.2 Million USD | 17.07% |
| 2006 FY | 627.61 Million USD | 0.65% |
| 2006 Q1 | 160.75 Million USD | 3.18% |
| 2006 Q3 | 196.09 Million USD | 4.19% |
| 2006 Q4 | 224.53 Million USD | 14.5% |
| 2005 Q2 | 167.95 Million USD | 9.64% |
| 2005 Q1 | 153.18 Million USD | 13.18% |
| 2005 FY | 623.54 Million USD | -18.22% |
| 2005 Q4 | 155.79 Million USD | 8.77% |
| 2005 Q3 | 143.23 Million USD | -14.72% |
| 2004 Q2 | 179.75 Million USD | 0.9% |
| 2004 Q3 | 155.25 Million USD | -13.63% |
| 2004 Q4 | 135.34 Million USD | -12.82% |
| 2004 FY | 762.46 Million USD | 13.56% |
| 2004 Q1 | 178.14 Million USD | -10.56% |
| 2003 Q2 | 177.42 Million USD | -5.38% |
| 2003 Q1 | 187.52 Million USD | 10.59% |
| 2003 Q4 | 199.18 Million USD | -4.1% |
| 2003 FY | 671.43 Million USD | 7.61% |
| 2003 Q3 | 207.7 Million USD | 17.07% |
| 2002 FY | 623.93 Million USD | 46.96% |
| 2002 Q4 | 169.57 Million USD | 1.71% |
| 2002 Q3 | 166.73 Million USD | 12.96% |
| 2002 Q2 | 147.6 Million USD | -8.28% |
| 2002 Q1 | 160.93 Million USD | -9.27% |
| 2001 Q4 | 177.37 Million USD | 8.3% |
| 2001 Q2 | 121.85 Million USD | 3.95% |
| 2001 Q1 | 117.22 Million USD | 1.01% |
| 2001 FY | 424.56 Million USD | -8.5% |
| 2001 Q3 | 163.77 Million USD | 34.4% |
| 2000 Q1 | 118.73 Million USD | -1.38% |
| 2000 Q4 | 116.05 Million USD | 9.22% |
| 2000 Q3 | 106.25 Million USD | 25.07% |
| 2000 Q2 | 84.95 Million USD | -28.45% |
| 2000 FY | 464.03 Million USD | 12.85% |
| 1999 FY | 411.2 Million USD | 56.95% |
| 1999 Q1 | 115.3 Million USD | 7.26% |
| 1999 Q2 | 105 Million USD | -8.93% |
| 1999 Q3 | 120 Million USD | 14.29% |
| 1999 Q4 | 120.4 Million USD | 0.33% |
| 1998 Q2 | 90.6 Million USD | 48.52% |
| 1998 FY | 262 Million USD | 32.46% |
| 1998 Q3 | 97.8 Million USD | 7.95% |
| 1998 Q4 | 107.5 Million USD | 9.92% |
| 1998 Q1 | 61 Million USD | 1.84% |
| 1997 Q1 | 48.7 Million USD | -6.88% |
| 1997 FY | 197.8 Million USD | -5.22% |
| 1997 Q4 | 59.9 Million USD | -32.09% |
| 1997 Q3 | 88.2 Million USD | 66.73% |
| 1997 Q2 | 52.9 Million USD | 8.62% |
| 1996 FY | 208.7 Million USD | -12.75% |
| 1996 Q2 | 46.9 Million USD | 7.57% |
| 1996 Q4 | 52.3 Million USD | 4.81% |
| 1996 Q3 | 49.9 Million USD | 6.4% |
| 1996 Q1 | 43.6 Million USD | -9.17% |
| 1995 Q1 | 64.5 Million USD | 6.09% |
| 1995 FY | 239.2 Million USD | 74.09% |
| 1995 Q2 | 62.1 Million USD | -3.72% |
| 1995 Q4 | 48 Million USD | -12.73% |
| 1995 Q3 | 55 Million USD | -11.43% |
| 1994 Q4 | 60.8 Million USD | 3.4% |
| 1994 Q1 | 37.1 Million USD | -2.88% |
| 1994 Q3 | 58.8 Million USD | 6.72% |
| 1994 Q2 | 55.1 Million USD | 48.52% |
| 1994 FY | 137.4 Million USD | 7.6% |
| 1993 Q3 | 29.4 Million USD | -9.82% |
| 1993 Q4 | 38.2 Million USD | 29.93% |
| 1993 FY | 127.7 Million USD | 90.31% |
| 1993 Q1 | 37.9 Million USD | -2.82% |
| 1993 Q2 | 32.6 Million USD | -13.98% |
| 1992 Q3 | 31.1 Million USD | 48.1% |
| 1992 Q1 | 21.3 Million USD | 21.02% |
| 1992 FY | 67.1 Million USD | 71.61% |
| 1992 Q2 | 21 Million USD | -1.41% |
| 1992 Q4 | 39 Million USD | 25.4% |
| 1991 Q3 | 11.6 Million USD | 12.62% |
| 1991 Q1 | 9.1 Million USD | -9.0% |
| 1991 Q4 | 17.6 Million USD | 51.72% |
| 1991 FY | 39.1 Million USD | -2.01% |
| 1991 Q2 | 10.3 Million USD | 13.19% |
| 1990 Q2 | 10.8 Million USD | -9.24% |
| 1990 FY | 39.9 Million USD | 4.72% |
| 1990 Q4 | 10 Million USD | 8.7% |
| 1990 Q1 | 11.9 Million USD | 14.42% |
| 1990 Q3 | 9.2 Million USD | -14.81% |
| 1989 Q2 | 8.8 Million USD | -59.07% |
| 1989 FY | 38.1 Million USD | -27.98% |
| 1989 Q1 | 21.5 Million USD | -3.15% |
| 1989 Q4 | 10.4 Million USD | 16.85% |
| 1989 Q3 | 8.9 Million USD | 1.14% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | -1395.176% |
| PainReform Ltd. | -15 Thousand USD | 42924100.0% |
| Alvotech | -69.42 Million USD | 9374.582% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | -1874.007% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | -2008.921% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | -21540.898% |
| Journey Medical Corporation | 52.52 Million USD | -12159.096% |
| Dynavax Technologies Corporation | 182.11 Million USD | -3435.42% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | -8711.912% |
| Bright Green Corporation | -237.01 Thousand USD | 2716625.467% |
| Pacira BioSciences, Inc. | 490.3 Million USD | -1213.172% |
| Embecta Corp. | 749.9 Million USD | -758.594% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -77109.113% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -77109.113% |
| SCYNEXIS, Inc. | 124.51 Million USD | -5070.86% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -153523.047% |
| Silver Spike Investment Corp. | 8.1 Million USD | -79363.392% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -1162163.007% |
| Alpha Teknova, Inc. | 10.29 Million USD | -62434.965% |
| Safety Shot Inc | -74.45 Thousand USD | 8647507.228% |
| Procaps Group, S.A. | 239.56 Million USD | -2587.576% |
| Cosmos Health Inc. | 4.34 Million USD | -147928.46% |
| Theratechnologies Inc. | 62.12 Million USD | -10263.276% |
| Harrow Health, Inc. | 90.55 Million USD | -7010.311% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -135592.308% |
| Biofrontera Inc. | 16.62 Million USD | -38623.763% |
| DURECT Corporation | 6.83 Million USD | -94155.599% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | -1129.346% |
| Cronos Group Inc. | 6.99 Million USD | -91999.782% |
| OptiNose, Inc. | 62.35 Million USD | -10225.881% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | -1359.47% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 2125050.495% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -210713.205% |
| Organogenesis Holdings Inc. | 309.79 Million USD | -1978.376% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -119254.522% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -19127.797% |
| Radius Health, Inc. | 307.71 Million USD | -1992.418% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -63788.437% |
| ProPhase Labs, Inc. | 16.23 Million USD | -39548.993% |
| Phibro Animal Health Corporation | 312.48 Million USD | -1960.438% |
| Procaps Group S.A. | 239.56 Million USD | -2587.576% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -494416.129% |
| Rockwell Medical, Inc. | 8.7 Million USD | -73872.886% |
| Aytu BioPharma, Inc. | 54.58 Million USD | -11695.332% |
| SIGA Technologies, Inc. | 122.09 Million USD | -5173.559% |
| Tilray Brands, Inc. | 223.35 Million USD | -2782.727% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | -15284.946% |
| Shineco, Inc. | 882.16 Thousand USD | -729760.979% |
| PetIQ, Inc. | 252.74 Million USD | -2447.519% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 863660.036% |
| Incannex Healthcare Limited | 12 Thousand USD | -53654900.0% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | -248.522% |
| Alimera Sciences, Inc. | 61.17 Million USD | -10425.748% |
| Assertio Holdings, Inc. | 125.04 Million USD | -5048.862% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 94532474.101% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | -98109.274% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 267242.317% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | -23643.777% |
| Hempacco Co., Inc. | -1.21 Million USD | 529662.859% |
| Talphera, Inc. | -4.89 Million USD | 131634.219% |
| Alvotech | -69.42 Million USD | 9374.582% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | -2804.535% |
| Lantheus Holdings, Inc. | 709.54 Million USD | -807.429% |
| Currenc Group, Inc. | 17.35 Million USD | -36996.606% |
| Kamada Ltd. | 52.59 Million USD | -12142.373% |
| Indivior PLC | 907 Million USD | -609.879% |
| Evoke Pharma, Inc. | 4.97 Million USD | -129221.591% |
| Flora Growth Corp. | 17.73 Million USD | -36198.343% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 267242.317% |
| Evolus, Inc. | 140.52 Million USD | -4481.786% |
| HUTCHMED (China) Limited | 453.55 Million USD | -1319.595% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | -1771.86% |
| Akanda Corp. | 111.44 Thousand USD | -5777071.621% |